由SARS-CoV-2感染引起的人类中和抗体
Bin Ju1,2, Qi Zhang3, Jiwan Ge4
1Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Shenzhen, China.
Nature
|May 27, 2020
概括
研究人员分离出针对SARS-CoV-2受体结合域 (RBD) 的强效中和抗体. 这些抗体通过与ACE2竞争来阻止病毒的进入,从而提供潜在的COVID-19疗法.
科学领域:
- 病毒学
- 免疫学
- 结构生物学
背景情况:
- 由SARS-CoV-2引起的COVID-19大流行需要有效的干预措施.
- SARS-CoV-2 进入宿主细胞依赖于尖端蛋白的 RBD 与 ACE2 受体的结合.
研究的目的:
- 针对SARS-CoV-2 RBD的单克隆抗体的分离和特征.
- 评估这些抗体的中和能力和机制.
主要方法:
- 从受感染个体中分离和表征206个RBD特异性单克隆抗体.
- 评估抗体中和性竞争.
- 对RBD结合抗体复合物的结构分析.
主要成果:
- 鉴定有力的SARS-CoV-2中和抗体.
- 中和活性与ACE2结合的竞争相关.
- 证明了阻断病毒进入的硬质阻碍机制.
- 观察到与 SARS-CoV 和 MERS-CoV RBD 的交叉反应缺乏.
结论:
- 抗RBD抗体主要是SARS-CoV-2的特定抑制剂.
- 已识别的抗体是针对COVID-19的临床开发的潜在候选者.
相关概念视频
Immune Response Against Viral Pathogens
1.5K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.5K
Cross-reactivity
32.7K
Overview
32.7K


